PIPRA closes CHF 2,1m Seed funding round
BV4's valuation experts Vuk Vegezzi and Christian Bückle held a masterclass around the topic of valuation at the Startup Days in Bern in May 2022. Review the session from and download the handout below.
History of PIPRA: PIPRA (short for Pre-Interventional Preventive Risk Assessment) has developed a CE certified cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery.
Transaction summary: BV4 acted as an independent fundraising advisor to PIPRA in its recent successful Seed funding round of CHF 2,1m. This oversubscribed Seed round has been funded by a group of Swiss and international investors, including Silicon Valley-based Plug and Play.
More on the collaboration between PIPRA and BV4:
BV4 supported PIPRA with its deal preparation offering in order to become investor ready. The mandate included the creation of a strong pitchdeck & storytelling, financial modelling as well as PIPRA's valuation. We are very excited for PIPRA and look forward to their continued success.
Find out more about PIPRA following the link below: